456 related articles for article (PubMed ID: 36092543)
1. Impact of Phytochemicals on PPAR Receptors: Implications for Disease Treatments.
Enayati A; Ghojoghnejad M; Roufogalis BD; Maollem SA; Sahebkar A
PPAR Res; 2022; 2022():4714914. PubMed ID: 36092543
[TBL] [Abstract][Full Text] [Related]
2. PPAR-Mediated Toxicology and Applied Pharmacology.
Xi Y; Zhang Y; Zhu S; Luo Y; Xu P; Huang Z
Cells; 2020 Feb; 9(2):. PubMed ID: 32028670
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome Proliferator-Activated Receptors and Their Agonists in Nonalcoholic Fatty Liver Disease.
Choudhary NS; Kumar N; Duseja A
J Clin Exp Hepatol; 2019; 9(6):731-739. PubMed ID: 31889755
[TBL] [Abstract][Full Text] [Related]
4. Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration.
Durai P; Beeraka NM; Ramachandrappa HVP; Krishnan P; Gudur P; Raghavendra NM; Ravanappa PKB
Curr Neuropharmacol; 2022; 20(5):893-915. PubMed ID: 34751120
[TBL] [Abstract][Full Text] [Related]
5. Safety issues and prospects for future generations of PPAR modulators.
Rubenstrunk A; Hanf R; Hum DW; Fruchart JC; Staels B
Biochim Biophys Acta; 2007 Aug; 1771(8):1065-81. PubMed ID: 17428730
[TBL] [Abstract][Full Text] [Related]
6. The role of peroxisome proliferator-activated receptors in healthy and diseased eyes.
Escandon P; Vasini B; Whelchel AE; Nicholas SE; Matlock HG; Ma JX; Karamichos D
Exp Eye Res; 2021 Jul; 208():108617. PubMed ID: 34010603
[TBL] [Abstract][Full Text] [Related]
7. Potential Therapeutic Effects of PPAR Ligands in Glioblastoma.
Basilotta R; Lanza M; Casili G; Chisari G; Munao S; Colarossi L; Cucinotta L; Campolo M; Esposito E; Paterniti I
Cells; 2022 Feb; 11(4):. PubMed ID: 35203272
[TBL] [Abstract][Full Text] [Related]
8. PPARs and the cardiovascular system.
Hamblin M; Chang L; Fan Y; Zhang J; Chen YE
Antioxid Redox Signal; 2009 Jun; 11(6):1415-52. PubMed ID: 19061437
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
Latruffe N; Vamecq J
Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701
[TBL] [Abstract][Full Text] [Related]
10. Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders.
Sanjay ; Sharma A; Lee HJ
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944727
[TBL] [Abstract][Full Text] [Related]
11. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
Gervois P; Fruchart JC; Staels B
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptors and the metabolic syndrome.
Bragt MC; Popeijus HE
Physiol Behav; 2008 May; 94(2):187-97. PubMed ID: 18191967
[TBL] [Abstract][Full Text] [Related]
13. Experimental approaches to study PPAR gamma agonists as antidiabetic drugs.
Vázquez M; Silvestre JS; Prous JR
Methods Find Exp Clin Pharmacol; 2002 Oct; 24(8):515-23. PubMed ID: 12500431
[TBL] [Abstract][Full Text] [Related]
14. Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
Tenenbaum A; Fisman EZ
Cardiovasc Diabetol; 2012 Nov; 11():140. PubMed ID: 23150952
[TBL] [Abstract][Full Text] [Related]
15. Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications.
Mirza AZ; Althagafi II; Shamshad H
Eur J Med Chem; 2019 Mar; 166():502-513. PubMed ID: 30739829
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.
Wagner N; Wagner KD
Cells; 2022 Aug; 11(15):. PubMed ID: 35954274
[TBL] [Abstract][Full Text] [Related]
17. Biology and therapeutic applications of peroxisome proliferator- activated receptors.
Menendez-Gutierrez MP; Roszer T; Ricote M
Curr Top Med Chem; 2012; 12(6):548-84. PubMed ID: 22242855
[TBL] [Abstract][Full Text] [Related]
18. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
Ahmed W; Ziouzenkova O; Brown J; Devchand P; Francis S; Kadakia M; Kanda T; Orasanu G; Sharlach M; Zandbergen F; Plutzky J
J Intern Med; 2007 Aug; 262(2):184-98. PubMed ID: 17645586
[TBL] [Abstract][Full Text] [Related]
19. The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways.
Kliewer SA; Lehmann JM; Milburn MV; Willson TM
Recent Prog Horm Res; 1999; 54():345-67; discussion 367-8. PubMed ID: 10548883
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present).
Takada I; Makishima M
Expert Opin Ther Pat; 2020 Jan; 30(1):1-13. PubMed ID: 31825687
[No Abstract] [Full Text] [Related]
[Next] [New Search]
